Sandro da Rocha, Ph.D.
Massey Cancer Center research program membership
Department of Chemical and Life Science Engineering,
College of Engineering
Department of Pharmaceutics,
School of Pharmacy
PhD, The University of Texas at Austin (2000)
MS, Federal University of Santa Catarina, Brazil (1995)
Our group focuses on the treatment of lung cancers. We seek to develop novel combination therapies that include nanomedicines, immunotherapy, and chemotherapy with the goal of improving qualify of life and rates of survival for lung cancer patients. We employ innovative polymer chemistry and perform in vitro and in vivo clinical studies to test our formulations.
Disease focus of research
Breast, Respiratory/lung, Sarcoma
Cancer therapy resistance,Cancer therapy toxicities,Immunotherapy,Metastasis,Tumor microenvironment
Published research (during tenure as a Massey Cancer Center member)
Search In PubMed